Accelerating the development of biomarkers for drug safety : workshop summary /

"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and prov...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation
Otros Autores: Olson, Steve, 1956-, Robinson, Sally, Giffin, Robert B.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press, ©2009.
Temas:
Biochemical markers > Congresses.
Drugs > Safety measures > Congresses.
Drugs > Testing > Congresses.
Drugs > Side effects.
Biochemical markers.
Drugs > Design.
Drug-Related Side Effects and Adverse Reactions
Biomarkers.
Drug Design
Drug Discovery
Marqueurs biologiques > Congrès.
Médicaments > Sécurité > Mesures > Congrès.
Médicaments > Essais cliniques > Congrès.
Médicaments > Effets secondaires.
Marqueurs biologiques.
Médicaments > Conception.
MEDICAL > Laboratory Medicine.
MEDICAL > Diagnosis.
MEDICAL > Nursing > Assessment & Diagnosis.
Drugs > Side effects
Drugs > Design
Biochemical markers
Drugs > Safety measures
Drugs > Testing
Congress
proceedings (reports)
Conference papers and proceedings
Conference papers and proceedings.
Actes de congrès.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Introduction
  • Overview Of key issues
  • Cardiac safety biomarkers
  • Assessing and predicting kidney safety
  • Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials
  • Future considerations.

Ejemplares similares